Kably-Ambe A, Reyes-Cuervo H, Barrón-Vallejo J
Unidad de Reproducción Asistida, Clínica de Infertilidad-Endoscopia y Embarazo de Alto Riesgo, México, D.F.
Ginecol Obstet Mex. 1996 Jul;64:293-6.
The objective was to evaluate the utility of the pure FSH as treatment of women clomiphene-resistant. Seventy two patients clomiphene-resistant were treated with pure FSH. Ovulation induction was started with 75 IU of pure FSH on day 3 of the menstrual cycle, monitoring the follicular growth with transvaginal ultrasonography, additional doses of pure FSH were administered accordingly. Human chorionic gonadotropin (10,000 IU) was administered when the dominant follicle reached a diameter > or = 16 mm. The pregnancy rate per cycle was 18.0%, on the other hand, the cumulate rate of pregnancy was 72.2%. There was not significant difference in the pregnancy rate between patients with primary or secondary infertility. The rate of spontaneous abortions was similar to the general population. As conclusion, it therefore appropriate to offer the treatment with pure FSH to patients clomiphene-resistance. The cases with gonadotropin-resistance, will be candidates to surgical procedures.
目的是评估单纯促卵泡生成素(FSH)治疗克罗米芬抵抗女性的效用。72例克罗米芬抵抗的患者接受了单纯FSH治疗。在月经周期第3天开始用75 IU单纯FSH进行促排卵,通过经阴道超声监测卵泡生长,并据此给予额外剂量的单纯FSH。当优势卵泡直径达到≥16 mm时,给予人绒毛膜促性腺激素(10,000 IU)。每个周期的妊娠率为18.0%,另一方面,累积妊娠率为72.2%。原发性或继发性不孕患者之间的妊娠率无显著差异。自然流产率与普通人群相似。因此,结论是向克罗米芬抵抗的患者提供单纯FSH治疗是合适的。促性腺激素抵抗的病例将是手术治疗的候选者。